Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers

AMD-3100, a bicyclam, is a novel agent that uniquely inhibits the entry of human immunodeficiency virus type 1 (HIV-1) into CD4(+) T cells via selective blockade of the chemokine CXCR-4 receptor. Twelve healthy volunteers were given AMD-3100 as a single 15-min intravenous infusion at 10, 20, 40, or...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Hendrix, Craig W., Flexner, Charles, MacFarland, Ronald T., Giandomenico, Christen, Fuchs, Edward J., Redpath, Ella, Bridger, Gary, Henson, Geoffrey W.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2000
Soggetti:	Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89930/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10817726/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.6.1667-1673.2000
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!